Abstract:Objective To analyze the clinical expressions of heparinase and basic fibroblast growth factor (bFGF) in the non-small cell lung cancer (NSCLC) tissues and their correlations with the lung cancer metastasis and prognosis. Methods Forty-eight NSCLC patients treated in Henan Provincial People’s Hospital from June 2012 to June 2014 were selected. During operation, the samples of lung cancer tissues were collected as the observation group, the samples of para-cancerous tissues were collected as the control group. The expressions of heparinase and bFGF were observed, their correlations with the clinical pathological characteristics were analyzed. Using logistic regression equation, the correlations of heparinase and bFGF expressions with the cancer metastasis and survival rate were analyzed. Results In the observation group, there were 38 heparinase-positive cases (79.17%) and 37 bFGFpositive cases (77.08%); in the control group, the heparinase and bFGF were negatively expressed, the differences were statistically significant between the two groups (P < 0.05). The heparinase expression was correlated with the NSCLC pathological staging, vascular invasion and lymphatic metastasis; the bFGF expression was correlated with the pathological staging, differentiation degree, vascular invasion and lymphatic metastasis. After 3 y of follow-up, 26 cases survived (54.17%) and 22 cases died (45.83%). The differentiation degree, vascular invasion, lymphatic metastasis and bFGF expression were significantly different between the survived cases and the dead cases (P < 0.05). The influencing factors of the prognosis included the differentiation degree, vascular invasion, lymphatic metastasis and bFGF expression. Conclusions The expressions of heparinase and bFGF are closely correlated with cancer metastasis and vascular invasion as well as the prognosis of NSCLC patients.